Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02998229 · ClinicalTrials.gov registry record · NA
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
A NA study of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 19
- Study locations
NCT02998229: Recruiting NA study of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT02998229 is a NA study of Intracranial Aneurysm that is actively recruiting participants, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 300 participants, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 19 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02998229, a NA study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Medtronic Neurovascular Clinical Affairs.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
Primary Outcome
Incidence of complete aneurysm occlusion without retreatment of the target aneurysm, recurrent subarachnoid hemorrhage (SAH) from the target aneurysm, or significant parent artery stenosis (\>50% stenosis) at 1 year post-procedure.
Conditions Studied
Interventions
- DEVICE Artisse™ Intrasaccular Device
Study Locations (19)
New York
- Albany Medical Center - Albany
- Buffalo General Medical Center - Buffalo
- The Mount Sinai Hospital - New York
- Stony Brook University Hospital - Stony Brook
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Thomas Jefferson University Hospital - Philadelphia
- UPMC Presbyterian - Pittsburgh
Florida
- Baptist Medical Center Jacksonville - Jacksonville
- Tampa General Hospital - Tampa
Illinois
- University of Chicago - Chicago
- Advocate Lutheran General Hospital - Park Ridge
Connecticut
- Yale New Haven Hospital - New Haven
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
North Carolina
- Novant Health Brain and Spine Surgery - Charlotte
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2032-02 |
| Phase | NA |
What NCT02998229 shows while recruiting
NCT02998229 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Artisse™ Intrasaccular Device is the first listed.
NCT02998229 lists 19 locations in 12 states (New York, Pennsylvania, Florida).
Frequently Asked Questions
What is clinical trial NCT02998229 about?
NCT02998229 is a clinical study titled "The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).". The purpose of this study is to assess the safety and effectiveness of the Artisse™ Intrasaccular Device in the treatment of unruptured and ruptured wide-neck bifurcating intracranial aneurysms.
What is the current status of trial NCT02998229?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-04-16. Estimated completion is 2032-02.
What conditions does trial NCT02998229 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT02998229?
The interventions under investigation include: Artisse™ Intrasaccular Device (DEVICE).
Who is sponsoring clinical trial NCT02998229?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02998229 being conducted?
This trial has 19 study locations across Connecticut, Florida, Illinois, Iowa, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02998229's enrollment target sits among peer trials
300 7th of 14 higher than 8 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
-
Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil
COMPLETED · NA
-
Neuroform Atlas Stent System Study
COMPLETED · NA
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI